The global active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) market was valued at USD 118.6 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2030. This growth is driven by several factors, including increased investments in drug research and development, rising rates of chronic...